Mutations in ZBTB24 Are Associated with Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome Type 2

Maraschio, 1988, Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: The ICF syndrome, J. Med. Genet., 25, 173, 10.1136/jmg.25.3.173

Hagleitner, 2008, Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome), J. Med. Genet., 45, 93, 10.1136/jmg.2007.053397

Hansen, 2003, X inactivation-specific methylation of LINE-1 elements by DNMT3B: Implications for the Lyon repeat hypothesis, Hum. Mol. Genet., 12, 2559, 10.1093/hmg/ddg268

Xu, 1999, Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene, Nature, 402, 187, 10.1038/46214

Okano, 1999, DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development, Cell, 99, 247, 10.1016/S0092-8674(00)81656-6

Gowher, 2002, Molecular enzymology of the catalytic domains of the Dnmt3a and Dnmt3b DNA methyltransferases, J. Biol. Chem., 277, 20409, 10.1074/jbc.M202148200

Jeanpierre, 1993, An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome, Hum. Mol. Genet., 2, 731, 10.1093/hmg/2.6.731

Tuck-Muller, 2000, DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients, Cytogenet. Cell Genet., 89, 121, 10.1159/000015590

Wijmenga, 2000, Genetic variation in ICF syndrome: Evidence for genetic heterogeneity, Hum. Mutat., 16, 509, 10.1002/1098-1004(200012)16:6<509::AID-HUMU8>3.0.CO;2-V

Jiang, 2005, DNMT3B mutations and DNA methylation defect define two types of ICF syndrome, Hum. Mutat., 25, 56, 10.1002/humu.20113

Kubota, 2004, ICF syndrome in a girl with DNA hypomethylation but without detectable DNMT3B mutation, Am. J. Med. Genet. A., 129A, 290, 10.1002/ajmg.a.30135

Kloeckener-Gruissem, 2005, A new and a reclassified ICF patient without mutations in DNMT3B and its interacting proteins SUMO-1 and UBC9, Am. J. Med. Genet. A., 136, 31, 10.1002/ajmg.a.30767

Brown, 1995, ICF syndrome (immunodeficiency, centromeric instability and facial anomalies): Investigation of heterochromatin abnormalities and review of clinical outcome, Hum. Genet., 96, 411, 10.1007/BF00191798

Wijmenga, 1998, Localization of the ICF syndrome to chromosome 20 by homozygosity mapping, Am. J. Hum. Genet., 63, 803, 10.1086/302021

Schuetz, 2007, ICF syndrome: High variability of the chromosomal phenotype and association with classical Hodgkin lymphoma, Am. J. Med. Genet. A., 143A, 2052, 10.1002/ajmg.a.31885

Gennery, 2007, Hematopoietic stem cell transplantation corrects the immunologic abnormalities associated with immunodeficiency-centromeric instability-facial dysmorphism syndrome, Pediatrics, 120, e1341, 10.1542/peds.2007-0640

Pezzolo, 2001, T-cell apoptosis in ICF syndrome, J. Allergy Clin. Immunol., 108, 310, 10.1067/mai.2001.116863

Gimelli, 1993, ICF syndrome with variable expression in sibs, J. Med. Genet., 30, 429, 10.1136/jmg.30.5.429

Colucci, 2004, Progressive multifocal leukoencephalopathy in an adult patient with ICF syndrome, J. Neurol. Sci., 217, 107, 10.1016/j.jns.2003.08.009

Lander, 1987, Homozygosity mapping: A way to map human recessive traits with the DNA of inbred children, Science, 236, 1567, 10.1126/science.2884728

Ng, 2010, Exome sequencing identifies the cause of a mendelian disorder, Nat. Genet., 42, 30, 10.1038/ng.499

Langmead, 2009, Ultrafast and memory-efficient alignment of short DNA sequences to the human genome, Genome Biol., 10, R25, 10.1186/gb-2009-10-3-r25

Li, 2009, The Sequence Alignment/Map format and SAMtools, Bioinformatics, 25, 2078, 10.1093/bioinformatics/btp352

Blanco-Betancourt, 2004, Defective B-cell-negative selection and terminal differentiation in the ICF syndrome, Blood, 103, 2683, 10.1182/blood-2003-08-2632

Bardwell, 1994, The POZ domain: A conserved protein-protein interaction motif, Genes Dev., 8, 1664, 10.1101/gad.8.14.1664

Deweindt, 1995, The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: A novel function for the BTB/POZ domain as an autonomous repressing domain, Cell Growth Differ., 6, 1495

Huynh, 1998, The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT, Oncogene, 17, 2473, 10.1038/sj.onc.1202197

Huynh, 2000, BCoR, a novel corepressor involved in BCL-6 repression, Genes Dev., 14, 1810, 10.1101/gad.14.14.1810

Reeves, 2001, HMGI/Y proteins: Flexible regulators of transcription and chromatin structure, Biochim. Biophys. Acta, 1519, 13, 10.1016/S0167-4781(01)00215-9

Stogios, 2005, Sequence and structural analysis of BTB domain proteins, Genome Biol., 6, R82, 10.1186/gb-2005-6-10-r82

Ye, 1995, Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma, EMBO J., 14, 6209, 10.1002/j.1460-2075.1995.tb00311.x

Dent, 1997, Control of inflammation, cytokine expression, and germinal center formation by BCL-6, Science, 276, 589, 10.1126/science.276.5312.589

Shaffer, 2000, BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control, Immunity, 13, 199, 10.1016/S1074-7613(00)00020-0

Phan, 2004, The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells, Nature, 432, 635, 10.1038/nature03147

Takamori, 2004, BAZF is required for activation of naive CD4 T cells by TCR triggering, Int. Immunol., 16, 1439, 10.1093/intimm/dxh144

Manders, 2005, BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytes, Proc. Natl. Acad. Sci. USA, 102, 7418, 10.1073/pnas.0501585102

Bilic, 2006, Negative regulation of CD8 expression via Cd8 enhancer-mediated recruitment of the zinc finger protein MAZR, Nat. Immunol., 7, 392, 10.1038/ni1311

Sun, 2005, The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection, Nat. Immunol., 6, 373, 10.1038/ni1183

He, 2005, The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment, Nature, 433, 826, 10.1038/nature03338

Piazza, 2004, Disruption of PLZP in mice leads to increased T-lymphocyte proliferation, cytokine production, and altered hematopoietic stem cell homeostasis, Mol. Cell. Biol., 24, 10456, 10.1128/MCB.24.23.10456-10469.2004

Kang, 2005, ROG negatively regulates T-cell activation but is dispensable for Th-cell differentiation, Mol. Cell. Biol., 25, 554, 10.1128/MCB.25.2.554-562.2005

Bilic, 2007, The role of BTB domain-containing zinc finger proteins in T cell development and function, Immunol. Lett., 108, 1, 10.1016/j.imlet.2006.09.007

Ehrlich, 2001, DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes, Hum. Mol. Genet., 10, 2917, 10.1093/hmg/10.25.2917

Jin, 2008, DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function, Hum. Mol. Genet., 17, 690, 10.1093/hmg/ddm341

Jefferson, 2010, Altered intra-nuclear organisation of heterochromatin and genes in ICF syndrome, PLoS ONE, 5, e11364, 10.1371/journal.pone.0011364

Matarazzo, 2007, Chromosome territory reorganization in a human disease with altered DNA methylation, Proc. Natl. Acad. Sci. USA, 104, 16546, 10.1073/pnas.0702924104

Ueda, 2006, Roles for Dnmt3b in mammalian development: A mouse model for the ICF syndrome, Development, 133, 1183, 10.1242/dev.02293

Miniou, 1997, alpha-satellite DNA methylation in normal individuals and in ICF patients: Heterogeneous methylation of constitutive heterochromatin in adult and fetal tissues, Hum. Genet., 99, 738, 10.1007/s004390050441